Comparative Pharmacology
Head-to-head clinical analysis: AZDONE versus PHENAZINE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: AZDONE versus PHENAZINE.
AZDONE vs PHENAZINE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
AZDONE is a selective serotonin reuptake inhibitor (SSRI) that potentiates serotonergic activity in the central nervous system by inhibiting the reuptake of serotonin at the presynaptic neuronal membrane.
Phenazine is a phenothiazine neuroleptic that blocks postsynaptic D2 dopamine receptors in the mesolimbic and mesocortical pathways, thereby alleviating positive symptoms of schizophrenia. It also has anticholinergic (M1 receptor blockade), alpha1-adrenergic receptor antagonism, and H1-histamine receptor antagonism properties, contributing to its adverse effect profile.
10 mg orally once daily
Phenazine is not a standard pharmaceutical agent. The name is ambiguous and may refer to a chemical compound (phenazine) or a historical preparation. No established dosing exists.
None Documented
None Documented
Clinical Note
moderateFluphenazine + Fluticasone propionate
"The risk or severity of adverse effects can be increased when Fluphenazine is combined with Fluticasone propionate."
Clinical Note
moderatePerphenazine + Fluticasone propionate
"The risk or severity of adverse effects can be increased when Perphenazine is combined with Fluticasone propionate."
Clinical Note
moderateFluphenazine + Haloperidol
"The metabolism of Haloperidol can be decreased when combined with Fluphenazine."
Clinical Note
moderateTerminal elimination half-life: 18 hours; clinically relevant for once-daily dosing
Terminal half-life approximately 6-10 hours; may be prolonged in hepatic or renal impairment, requiring dose adjustment.
Renal: 60% unchanged; fecal: 30% as metabolites; biliary: 10% as conjugates
Primarily renal (up to 80% as unchanged drug and metabolites), with approximately 15% biliary/fecal elimination.
Category C
Category C
Urinary Analgesic
Urinary Analgesic
Perphenazine + Haloperidol
"The metabolism of Haloperidol can be decreased when combined with Perphenazine."